Allergan Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Allergan (AGN) Tops Q1 EPS by 24c, Offers Q2 and Updated FY Guidance
May 7, 2019 7:03 AM EDTAllergan (NYSE: AGN) reported Q1 EPS of $3.79, $0.24 better than the analyst estimate of $3.55. Revenue for the quarter came in at $3.6 billion versus the consensus estimate of $3.54 billion.
GUIDANCE:
Allergan sees FY2019 EPS of $16.55, versus the consensus of $16.43. Allergan sees FY2019... More
